Estimaciones de analistas de Wall Street para None (SRTS): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 6 |
| Mantener | 3 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 9 |
| Calificación media (1-5) | 0.67 |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $14.8M | $20.6M | $26.4M | $27.3M | $9.6M | $27.0M | $44.5M | $24.4M | $41.8M | $27.5M |
| Coste de Ventas | $5.0M | $6.8M | $9.5M | $9.7M | $4.3M | $10.1M | $14.9M | $10.3M | $17.4M | $15.6M |
| Beneficio Bruto | $9.8M | $13.8M | $16.9M | $17.6M | $5.2M | $17.0M | $29.6M | $14.1M | $24.4M | $11.9M |
| I+D | $1.8M | $5.5M | $6.3M | $6.4M | $4.2M | $3.4M | $3.5M | $3.7M | $4.2M | $7.8M |
| Generales y Administrativos | $8.4M | $12.0M | $12.7M | $13.1M | $9.3M | $9.4M | $11.3M | $10.8M | $12.1M | $14.4M |
| Gastos Operativos | $10.2M | $17.5M | $18.9M | $19.5M | $13.5M | $12.9M | $14.8M | $14.4M | $16.3M | $22.2M |
| Beneficio Operativo | -$363119 | -$3.7M | -$2.0M | -$2.0M | -$8.2M | $4.1M | $14.8M | -$382000 | $8.1M | -$10.3M |
| EBITDA | $13002 | -$3.3M | -$1.2M | -$1.2M | -$6.1M | $4.7M | $28.5M | $1.1M | $9.5M | -$9.2M |
| Gastos por Intereses | $21867 | $68881 | $156685 | 0 | $14000 | $1000 | $2000 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$346448 | -$3.7M | -$2.0M | -$1.7M | -$6.8M | $4.1M | $28.0M | $652000 | $9.0M | -$9.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | $3.7M | $167000 | $2.4M | -$1.9M |
| Beneficio Neto | -$346448 | -$3.7M | -$2.0M | -$1.7M | -$6.8M | $4.1M | $24.2M | $485000 | $6.6M | -$7.7M |
| BPA | $-0.03 | $-0.28 | $-0.14 | $-0.07 | $-0.42 | $0.25 | $1.47 | $0.03 | $0.41 | $-0.47 |
| BPA Diluido | $-0.03 | $-0.28 | $-0.14 | $-0.07 | $-0.42 | $0.25 | $1.46 | $0.03 | $0.41 | $-0.47 |
| Acciones en Circulación (Diluidas) | $12.0M | $13.2M | $14.1M | $16.2M | $16.4M | $16.5M | $16.6M | $16.3M | $16.4M | $16.3M |
Empresas relacionadas: BDMD · CTSO · ICCM · IPSC · KPTI · MDAI · MDCX
Más secciones de SRTS: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones